Crispr Therapeutics shares owned by Alpine Woods Capital Investors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Alpine Woods Capital Investors
from 13F filings
Historical chart of Alpine Woods Capital Investors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Alpine Woods Capital Investors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Alpine Woods Capital Investors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $314k | 5.7k | 54.86 |
2021-12-31 | $3.2M | 43k | 75.78 |
2021-09-30 | $7.6M | 68k | 111.93 |
2021-06-30 | $11M | 68k | 161.89 |
2021-03-31 | $4.8M | 40k | 121.86 |
2020-12-31 | $5.4M | 35k | 153.12 |
2020-09-30 | $2.4M | 28k | 83.65 |
2020-06-30 | $1.8M | 25k | 73.50 |
2020-03-31 | $600k | 14k | 42.41 |
2019-12-31 | $616k | 10k | 60.94 |
2019-09-30 | $416k | 10k | 40.95 |
2019-06-30 | $478k | 10k | 47.06 |
2019-03-31 | $363k | 10k | 35.74 |
2018-12-31 | $290k | 10k | 28.55 |
2018-09-30 | $449k | 10k | 44.39 |
More positions owned by Alpine Woods Capital Investors
View all positions for Alpine Woods Capital Investors